Inivata

Inivata is a liquid biopsy technology research and development company headquartered in Massachusetts, USA. It is committed to developing applications for analyzing circulating tumor DNA (ctDNA) to improve detection technologies and treatment options in the field of oncology. By harnessing the emerging potential of circulating DNA analysis, Inivata aims to enhance testing and treatment for oncologists and their patients. Unlike traditional invasive biopsies, Inivata can detect and analyze genomic material from cell-free circulating tumor DNA (ctDNA) in cancer patients through simple blood sample collection. This non-invasive method—liquid biopsy—has revolutionized how cancer is detected, monitored, and treated. The company has developed TAm-Seq technology, which allows for the collection, detection, and analysis of genomic material from cell-free ctDNA in cancer patients via blood samples.